Association of TGF-β1 gene polymorphisms in exon1 and blood levels with essential hypertension

Blood Pressure

Volumn 19, Issue 4, 2010, Pages 225-233

  He, Fang ^a,b   Zhao, Dan ^b   Deng, Fengmei ^b   Zhong, Hua ^b   Shi, Xiaopeng ^b   Yang, Jianfeng ^b   Guo, Shuxia ^b   Cheng, Jiang ^b   Huang, Gang ^b   Tang, Bin ^b   Wang, Zhenhuan ^b   Chen, Xiongying ^b   Wang, Gang ^b   Zhang, Wanjiang ^b   Zhang, Chunjun ^b   Wang, Xuewen ^b   Hu, Qinghua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

Blood level; Gene polymorphism; Hypertension; Kazakh Chinese; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ADOLESCENT; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CHINA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HYPERTENSION; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHINA; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 77955317685     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051003768254     Document Type: Article

References (32)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556.
2. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, et al. Genome-wide mapping of human loci for essential hypertension. Lancet. 2003; 361:2118-2123.
3. Gong M, Zhang H, Schulz H, Lee YA, Sun K, Bahring S, et al. Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Hum Mol Genet. 2003;12:1273-1277.
4. de Lange M, Spector TD, Andrew T. Genome-wide scan for blood pressure suggests linkage to chromosome 11, and replication of loci on 16, 17, and 22. Hypertension. 2004; 44:872-877.
5. Wallace C, Xue MZ, Newhouse SJ, Marcano AC, Onipinla AK, Burke B, et al. Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension. Am J Hum Genet. 2006;79:323-331.
6. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349:1353-1357.
7. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998;18:45-48.
8. Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H, Yokota M. Prediction of genetic risk for hypertension. Hypertension. 2003;41:1035-1040.
9. Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Hibino T, et al. Assessment of the genetic component of hypertension. Am J Hypertens. 2006;19:1158-1165.
10. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014-1020.
11. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de lInfarctus du Myocarde (ECTIM) Study. Hypertension. 1996;28:881-887.
12. Park BL, Han IK, Lee HS, Kim LH, Kim SJ, Shin HD. Identification of novel variants in transforming growth factor-beta 1 (TGFB1) gene and association analysis with bone mineral density. Hum Mutat. 2003;22:257-258.
13. Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone. 1997;20:289-294.
14. Watanabe Y, Kinoshita A, Yamada T, Ohta T, Kishino T, Matsumoto N, et al. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway. J Hum Genet. 2002;47:478-483.
15. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93-97.
16. El-Gamel A, Awad MR, Hasleton PS, Yonan NA, Hutchinson JA, Campbell CS, et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant. 1999;18:517-523.
17. Group PNBPSC. Prevalence and development trends of hypertension in China. Chin J Hypertens. 1995;1:7 13.
18. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond). 1998;95:659-667.
19. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97-98.
20. Wang H, Mengsteab S, Tag CG, Gao CF, Hellerbrand C, Lammert F, et al. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol. 2005;11:1929-1936.
21. Zhang Y, Liu B, Jin M, Ni Q, Liang X, Ma X, et al. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: A population-based case-control study in China. Cancer Lett. 2009;275:102-108.
22. Lee JG, Ahn C, Yoon SC, Park JH, Eo HS, No JJ, et al. No association of the TGF-beta1 gene polymorphisms with the renal progression in autosomal dominant polycystic kidney disease (ADPKD) patients. Clin Nephrol. 2003;59:10-16.
23. Ohtsuka T, Yamakage A, Yamazaki S. The polymorphism of transforming growth factor-beta1 gene in Japanese patients with systemic sclerosis. Br J Dermatol. 2002;147:458-463.
24. Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, Sakurai M, et al. Transforming growth factor-beta-1 genetic poly morphism in Japanese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2003;18:1139-1143.
25. Hu BC, Chu SL, Wang JG, Wang GL, Gao PJ, Zhu DL. Single nucleotide polymorphisms of three candidate genes in essential hypertension. Zhonghua Nei Ke Za Zhi. 2006;45: 281-284.
26. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res. 1998;13:1569-1576.
27. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A. 2000;97:3479-3484.
28. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res. 2003;63:2610-2615.
29. Hinke V, Seck T, Clanget C, Scheidt-Nave C, Ziegler R, Pfeilschifter J. Association of transforming growth factor-beta1 (TGFbeta1) T29 C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women. Calcif Tissue Int. 2001;69:315-320.
30. Dick IM, Devine A, Li S, Dhaliwal SS, Prince RL. The T869C TGF beta polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women. Bone. 2003;33:335-341.
31. Mohren S, Weiskirchen R. Non-synonymous gene polymorphisms in the secretory signal peptide of human TGFbeta1 affect cellular synthesis but not secretion of TGF-beta1. Biochem Biophys Res Commun. 2009;379:1015-1020.
32. The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299-1320.